Onconetix (ONCO) Earnings Date & Reports

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for menâ€™s health and oncology... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ONCO is expected to report earnings to rise 10.53% to -20 cents per share on March 07

Q4'23

Est.

$-0.21

Q3'23

Est.

$-0.19

Q2'23

Missed

by $0.06

Q1'23

Beat

by $0.02

Q4'22

Beat

by $0.05

The last earnings report on November 09 showed earnings per share of -18 cents, meeting the estimate of -18 cents. With 7.65M shares outstanding, the current market capitalization sits at 959.98K.

View a ticker or compare two or three

Compare

ONCO